3D Systems Earnings Call: Momentum Amid Ongoing Turnaround

3D Systems Corp ((DDD)) has held its Q4 earnings call. Read on for the main highlights of the call.

3D Systems Corp’s latest earnings call painted a cautiously optimistic picture, with management stressing momentum in sequential growth, major wins in aerospace and personalized health, and cost cuts running ahead of plan. Yet executives were clear that year-over-year revenue remains down, margins are under pressure, and macro and geopolitical uncertainty still cloud the path to a full recovery.

Sequential Revenue Recovery and Q4 Outperformance

Q4 consolidated revenue reached $106.3 million, up 16% from Q3 and ahead of the 8%–10% growth range the company had guided to. Management credited stronger printer and materials demand tied to recent product launches, underscoring that execution is improving even as the broader demand backdrop remains uneven.

Industrial and Healthcare Sequential Growth

Industrial Solutions generated $55.8 million of revenue, a 15% sequential gain, while Healthcare Solutions climbed 18% sequentially to $50.5 million. The tandem growth across both segments suggests that the rebound is broad-based rather than confined to a single vertical, providing a more solid foundation for future quarters.

Aerospace & Defense Growth and 2026 Outlook

Aerospace and defense revenue advanced 16% year over year in 2025, and management is targeting more than 20% growth in 2026. That acceleration is expected to come from both casting-related polymer workflows and direct metal printing, reinforcing A&D as a central pillar of the company’s long-term strategy.

Personalized Health Services Expansion

Personalized Health Services posted double-digit growth in 2025 and is now the largest healthcare segment for 3D Systems. The business delivered over 18,000 personalized planning cases during the year, surpassing 400,000 patients served in total, and produced more than 260,000 customized implants, with FDA and CE-cleared devices now exceeding 100.

Commercial Launch of NextDent Jetted Denture Platform

The company began commercial U.S. shipments of its NextDent jetted denture platform in Q4, marking a key milestone in dental. Management highlighted that the solution can cut chair time and reduce manual lab labor by 40%–70%, and sees a long-term recurring materials revenue opportunity of more than $400 million globally if adoption scales as envisioned.

Cost Reduction Execution

Cost-cutting initiatives delivered roughly $55 million in annualized savings during 2025, beating the $50 million target set by management. As a result, full-year non-GAAP operating expenses fell 19% to $196 million, while Q4 non-GAAP operating expenses declined 23% year over year to $43 million on an adjusted basis, strengthening the path toward profitability.

Improved Adjusted EBITDA and Per-Share Loss

Adjusted EBITDA loss in Q4 narrowed to $5.3 million, an improvement of $17 million from the prior year after adjustments. For 2025 as a whole, adjusted EBITDA was a negative $45.4 million, but that still marked a $31 million year-over-year improvement, with non-GAAP loss per share shrinking to $0.37 from $0.62.

Balance Sheet and Liquidity Actions

3D Systems closed Q4 with $97.1 million in total cash, giving it a reasonable liquidity cushion as it continues restructuring and growth investments. The firm also executed an equitization to retire most of the debt previously maturing in late 2026, leaving only $3.9 million of that tranche and pushing roughly $92 million of obligations out to 2030.

Capacity Expansion to Support A&D Demand

To capitalize on rising U.S. aerospace and defense demand, the company announced up to 80,000 square feet of new capacity in Littleton, Colorado. The expansion is designed to bolster application development, process qualification, and production-scale manufacturing, strengthening 3D Systems’ positioning with key government and commercial A&D customers.

Full Year Revenue Decline

Despite the stronger finish, full-year 2025 revenue came in at $387 million and fell year over year when adjusted for the Geomagic divestiture. On a comparable basis, revenue declined 7%, or 9% when also adjusting for a regenerative medicine accounting item in the prior year, underscoring that the recovery is not yet visible on an annual run-rate basis.

YoY Q4 Revenue Pressure After Adjustments

Q4 revenue increased 3% year over year when excluding Geomagic, but turned into a 5% decline when also stripping out the prior regenerative medicine adjustment. Management framed this as lingering demand weakness in certain markets, which partly offsets the positive message from the sequential rebound in the quarter.

Gross Margin Compression

Non-GAAP gross margin in Q4 was 31%, and for 2025 it was 34.3%, down about 70 basis points on an adjusted basis and roughly 2 percentage points including regenerative medicine effects. The margin erosion was driven by lower overall volumes and a less favorable product mix, reinforcing that mix and scale remain critical levers for earnings.

Profitability Still Negative on Annual Basis

While losses narrowed, 3D Systems still ended 2025 in the red, with adjusted EBITDA of negative $45.4 million and a non-GAAP loss per share of $0.37. Management emphasized that the combination of cost savings and growth in higher-value segments is moving the company in the right direction, but the journey to sustainable profitability is not finished.

Softness in Industrial Printer and Materials Demand

The year-over-year revenue decline largely reflected weaker demand for industrial printers and related materials, areas that have been sensitive to macro headwinds and deferred capital spending. That weakness contrasted with the double-digit growth posted in priority segments like personalized health and aerospace and defense, which are increasingly driving the company’s mix.

Lower-Margin Product Mix Pressure

The strong Q4 was heavily fueled by sales of new printers, which carry lower margins than recurring materials and services. Management acknowledged that this mix limited margin pull-through in the quarter but argued that installed-base growth lays the groundwork for a richer stream of higher-margin consumables revenue over time.

Macroeconomic and Geopolitical Uncertainty; Limited Guidance

Executives cited ongoing macroeconomic and geopolitical uncertainty as a key reason for giving only near-term guidance. The company expects Q1 2026 revenue between $91 million and $94 million, implying a sequential decline from Q4, and projects an adjusted EBITDA loss of $5 million to $3 million, signaling continued near-term operating losses.

Reliance on Adoption Timelines in Dental Opportunity

Management called out the NextDent denture platform as a major long-term growth vector, but noted that the timing of the potential $400 million materials opportunity hinges on adoption rates among labs and clinicians. Conversion speed and workflow integration remain execution risks that could delay or dampen the full revenue ramp from dental.

Forward-Looking Guidance and Outlook

Looking ahead, 3D Systems is bracing for a softer Q1 but expects quarter-over-quarter gross margin improvement and reiterated its commitment to tight cost discipline, with operating expenses peaking seasonally in the first half and stepping down more sharply in the back half as savings fully materialize. Management also reaffirmed its target of more than 20% growth in aerospace and defense in 2026, positioning that segment as a key engine for future expansion.

The earnings call left investors weighing clear operational progress against unresolved profitability and demand questions, with sequential growth, expanding A&D and health franchises, and a cleaner balance sheet standing out as positives. At the same time, ongoing margin compression, industrial softness, and cautionary guidance underline that 3D Systems is still in turnaround mode, offering upside potential but with meaningful execution and macro risk attached.